Pharmacokinetics of CAMPATH-1H: assay development and validation
- 6 December 2001
- journal article
- Published by Elsevier in Journal of Immunological Methods
- Vol. 260 (1-2) , 285-302
- https://doi.org/10.1016/s0022-1759(01)00556-7
Abstract
No abstract availableKeywords
This publication has 21 references indexed in Scilit:
- CAMPATH-1H IN RHEUMATOID ARTHRITIS—AN INTRAVENOUS DOSE-RANGING STUDYRheumatology, 1996
- An improved assay for antibody dependent cellular cytotoxicity based on time resolved fluorometryJournal of Immunological Methods, 1995
- Characterization of the CAMPATH‐1 (CDw52) antigen: biochemical analysis and cDNA cloning reveal an unusually small peptide backboneEuropean Journal of Immunology, 1991
- A simple method for measuring patient anti-globulin responses against isotypic or idiotypic determinantsJournal of Immunological Methods, 1990
- IMPORTANCE OF ANTIGEN SPECIFICITY FOR COMPLEMENT‐MEDIATED LYSIS BY MONOCLONAL ANTIBODIESEuropean Journal of Immunology, 1988
- Reshaping human antibodies for therapyNature, 1988
- Complex translocation t(8;12;14) in a cell line derived from a child with nonendemic Burkitt-type acute lymphoblastic leukemiaCancer Genetics and Cytogenetics, 1987
- Reactivity of rat monoclonal antibody CAMPATH‐1 with human leukaemia cells and its possible application for autologous bone marrow transplantationBritish Journal of Haematology, 1985
- Human cutaneous T cell lymphoma and leukemia cell lines produce and respond to T cell growth factorThe Journal of Experimental Medicine, 1981
- A rapid solid-phase enzyme-linked binding assay for screening monoclonal antibodies to cell surface antigensJournal of Immunological Methods, 1981